Skip to main content

Fibromyalgia/Pain

      What happens if you have #axSpA & concomitant #FM?

      Pts with both have less TNFi retention,
      -residual pain may lead

      Janet Pope Janetbirdope

      1 month 1 week ago
      What happens if you have #axSpA & concomitant #FM? Pts with both have less TNFi retention, -residual pain may lead to d/c Rx. Need to determine if axSpA pt has #fibromyalgia as there may not be objective findings if no peripheral arthritis in axSpA. #ACR25 @RheumNow abst#534
      In a PsA cohort (n=1291), higher BMI was independently linked to lower odds of achieving MDA—especially in TNFi-treate

      Antoni Chan MD (Prof) synovialjoints

      1 month 1 week ago
      In a PsA cohort (n=1291), higher BMI was independently linked to lower odds of achieving MDA—especially in TNFi-treated patients. Impact was strongest in pain, skin, enthesitis, and PRO domains, not swollen joints. Each unit increase in BMI reduced MDA odds by 4–7%. Highlights https://t.co/TxO3HP51uk
      Abstract 2687: GLP-1 RA in PsA
      In combined Toronto + NYU cohort, GLP-1 RA significantly associated with reduced:
      - Weig

      Akhil Sood MD, MS AkhilSoodMD

      1 month 1 week ago
      Abstract 2687: GLP-1 RA in PsA In combined Toronto + NYU cohort, GLP-1 RA significantly associated with reduced: - Weight, CRP, and pain scores - Each 1% reduction in body weight associated w/ TJC, DAPSA, EQ-5D (QoL), LDL, Systolic BP @RheumNow #ACR25 https://t.co/30lPDkALKs
      #ACR25 Clinical Preview by Prof Coates for use now:

      GLP-1 agonist & Diet

      Abstr#813 GIP/GLP-1 improved MSK pain

      A

      Md Yuzaiful Md Yusof Yuz6Yusof

      1 month 1 week ago
      #ACR25 Clinical Preview by Prof Coates for use now: GLP-1 agonist & Diet Abstr#813 GIP/GLP-1 improved MSK pain Abstr#849 GLP-1 reduced risk of #MACE in PsA Abstr#2690 RCT = the degree of weight loss regardless specific dietary strategy determined benefit in PsA @RheumNow https://t.co/4jB0fFHosC
      From Pain to Wellness in PsA
      What's the latest in PsA?
      Perhaps it was my ignorance, but a FDA-approved therapy for fibromyalgia was not on my 2025 bingo card.

      We’re not exa

      David Liew drdavidliew

      1 month 1 week ago
      Perhaps it was my ignorance, but a FDA-approved therapy for fibromyalgia was not on my 2025 bingo card. We’re not exactly overwhelmed with proven options for FM, the unmet need is so great, so the more, the better. #ACR25 FDA session @RheumNow https://t.co/wwWijl3IyW
      Hindosh et al. Semaglutide associated with reduced synovitis, joint pain and swelling, in RA. @RheumNow #ACR25 Abstr#228

      Richard Conway RichardPAConway

      1 month 1 week ago
      Hindosh et al. Semaglutide associated with reduced synovitis, joint pain and swelling, in RA. @RheumNow #ACR25 Abstr#2286 https://t.co/6Xs4um5l32
      Gender differences in p/axSpA in Turkiye from ASAS-PerSpA:

      Males - early onset IBP (<45yrs); sacroiliitis on CR, HL

      sheila RHEUMarampa

      1 month 1 week ago
      Gender differences in p/axSpA in Turkiye from ASAS-PerSpA: Males - early onset IBP (<45yrs); sacroiliitis on CR, HLA-B27+ (vs. females) Females - peripheral dse, enthesitis, Pso, dactylitis; ⬆️dse activity, FM (vs. males) Individualize & optimize tx. #ACR25 @RheumNow Abs2322 https://t.co/vcisNguJLB
      ×